# Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

> **NCT04344444** · PHASE3 · TERMINATED · sponsor: **LCMC Health** · enrollment: 22 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT04344444
- **Lead sponsor:** LCMC Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-13
- **Primary completion:** 2021-04-10
- **Final completion:** 2022-01-05
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Lack of efficacy data from other studies
- **Last updated:** 2022-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344444, "Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04344444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*